(Total Views: 119)
Posted On: 10/04/2022 12:27:15 PM
Post# of 21261

$NBIO News...
https://finance.yahoo.com/news/nascent-begins...00290.html
*Announced today that the Company has enrolled the first patient of the fifth and final cohort of its Phase I clinical trial to evaluate Pritumumab ("PTB"
as a treatment for Primary and Metastatic Brain Cancers.
*This cohort of patients will likely be the final one in this trial.
https://finance.yahoo.com/news/nascent-begins...00290.html
*Announced today that the Company has enrolled the first patient of the fifth and final cohort of its Phase I clinical trial to evaluate Pritumumab ("PTB"

*This cohort of patients will likely be the final one in this trial.

